DPHil Students: Carl welcomes informal contacts from prospective students interested in using evidence-based approaches to improve healthcare in the following areas:
- NonCommunicable Diseases and/or self care approaches
- Using evidence-based methods to improve global health
- Evidence synthesis and systematic reviews
- Implementation of evidence in Primary Care settings
- Improving appropriate diagnosis and reducing overdiagnosis
- Enhancing the public understanding of EBM
- Improving drug and device regulation
- Evaluating healthcare interventions
Current projects can be viewed on the CEBM project page. All students gain the opportunity to teach and participate in the CEBM's dissemination and media activities. In the first instance students should contact firstname.lastname@example.org with an enquiry.
- Stroke Prevention and Atrial Fibrillation Research Group
- Cancer Research Research Group
- Monitoring and Diagnosis (MaDOx) Research Group
- Infectious Diseases Research Group Research Group
- Paediatric Research Group Research Group
- WHO Collaborating Centre for Self-Care Research Group
- Centre for Evidence Based Medicine Research Group
- Hypertension Research Group
BM, BCH, MA, MRCGP, DPhil
Professor of Evidence-Based Medicine
- Director of the Centre for Evidence-Based Medicine
- Director of Programs in EBHC
- Senior Tutor, Kellogg College
- NHS Honorary Clinical Consultant and NHS Urgent Care GP
Carl is a clinical epidemiologist and a world leading expert in EBM and research methods. His work focuses on changing healthcare both nationally and internationally for the better. He has extensive experience in systematic reviews and quantitative methodologies focusing on both communicable and NonCommunicable (NCD) diseases. He has also led groundbreaking work, which notably includes the tamiflu systematic reviews, and he is Director of a World Health Organization Collabaration Centre in Self Care.
Carl's work also includes investigating the evidence base for drug and device regulation, advising governments on the regulatory and evidence requirements for devices and drugs and evidence-based projects in the public interest.He has worked with Panorama to examine the evidence for sports drinks and for IVF 'Add-on' treatments, and with channel 4 and the BMJ he exposed problems with metal-hips. His international expertise in assessing evidence has been recognised by multiple global agencies including the WHO, US FDA and the UK government amongst others.
He is a founder of the AllTrials campaign and has chaired WHO guidelines on self-care and CVD risk. He is a co-PI on 4 mutli-centre RCTs and is chair of two NIHR Trial Steering Committees. His work also includes evaluating practice based interventions and influencing policy; and in 2013 and 2015 he was voted one of the top 100 NHS clinical leaders by the HSJ.
Carl is Director of the Centre for Evidence-Based Medicine (CEBM), which is dedicated to the practice, teaching and dissemination of high quality EBM. CEBM devotes a large proportion of its time to capacity building through outreach teaching and training activities - making EBM accessible to a wide range of healthcare professionals. He has considerable experience in teaching undergraduates, postgraduates and teachers of EBM, and is the Director of Programs in Evidence-Based Health Care, in conjunction with the Department of Continuing Education. This program currently has 85 Masters Students and 30 DPhil students. He also co-ordinates the Teaching Evidence-Based Practice week in Oxford, now in its 21th year. The course has trained over a 1000 teachers worldwide.
He is a board member of the NIHR School for Primary Care Research.
Carl has over 250 peer reviewed publications and has co-authored the EBM toolkit (BMJ-Blackwell’s), the Statistics Toolkit (BMJ-Blackwell’s) and is an editor of a series of BMJ-Blackwell’s toolkits and, developed with the BMJ the ‘Doctors Toolbag’ iPhone application and the EvidenceLive conference, now in its 6th year.
He runs an active twitter account (@carlheneghan)
Conflicts of interest and payments:
Carl Heneghan has received expenses and payments for his media work. He has received expenses from the WHO the US FDA, and holds grant funding from the NIHR, the NIHR School of Primary Care Research, The Wellcome Trust and the WHO. In addition, he is an expert witness in an ongoing medical device legal case, and has received financial renumeration from an asbestos case. He has also receives income from the publication of a series of toolkit books published by Blackwells. On occasion he receives expenses for teaching EBM and is also paid for his GP work in out of hours in Oxford. CEBM jointly runs the EvidenceLive Conference with the BMJ and the Overdiagnosis Conference with a number of international partners which are based on a non profit making model.